However, statins may have adverse effects, the most common of which are myopathy, which may occur in 510% of statin users 2 , and new-onset diabetes 3,4,5,6,7
In late 2023, the FDA explicitly removed BPC-157 from the list of substances compounding pharmacies may use in preparation for human administration a meaningful regulatory signal
Metabolic profiling of alternative NAD biosynthetic routes in mouse tissues
Risk Tolerance and Side Effects Tesamorelin, due to its strong GH-releasing effect, may lead to: Joint discomfort Swelling or redness at the injection site Elevated blood glucose Sermorelin, by contrast, typically causes fewer side effects such as: Mild headaches Injection site irritation Occasional nausea or dizziness Those with sensitive systems or pre-existing conditions may benefit more from Sermorelins gentler action
Drugs 15 , 190 (2017)